Platform for conducting vaccine studies

We offer:

  • a multidisciplinary research team.
  • Integrated translational research.
  • State-of-the-art infrastructure.
  • Phase I vaccine research platform.
  • Platform for clinical studies on antimicrobial resistance.
  • 'bedside to bench' delivery timelines to quickly adjust the vaccine development process.
  • High-tech Cellular Immunology facilities, including GMP cell processing units.



⇒ A combination of high quality  infrastructure with state-of-the-art 
     technology for biomarker identification and diagnostic development